Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
Author | |
---|---|
Abstract | :
Recent work has shown that the novel compound N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) may selectively block nicotinic acetylcholine receptors involved in regulating dopamine release. The current experiments examined the acute effect of bPiDDB on nicotine self-administration, sucrose-maintained responding, and nicotine-induced changes in acute and sensitized locomotor activity. |
Year of Publication | :
2006
|
Journal | :
Psychopharmacology
|
Volume | :
184
|
Issue | :
3-4
|
Number of Pages | :
426-34
|
ISSN Number | :
0033-3158
|
URL | :
https://doi.org/10.1007/s00213-005-0163-8
|
DOI | :
10.1007/s00213-005-0163-8
|
Short Title | :
Psychopharmacology (Berl)
|
Download citation |